Cargando…

Preserved blood-brain barrier and neurovascular coupling in female 5xFAD model of Alzheimer’s disease

INTRODUCTION: Dysfunction of the cerebral vasculature is considered one of the key components of Alzheimer’s disease (AD), but the mechanisms affecting individual brain vessels are poorly understood. METHODS: Here, using in vivo two-photon microscopy in superficial cortical layers and ex vivo imagin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhukov, Oleg, He, Chen, Soylu-Kucharz, Rana, Cai, Changsi, Lauritzen, Andreas D., Aldana, Blanca Irene, Björkqvist, Maria, Lauritzen, Martin, Kucharz, Krzysztof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228387/ https://www.ncbi.nlm.nih.gov/pubmed/37261266 http://dx.doi.org/10.3389/fnagi.2023.1089005

Ejemplares similares

Apolipoprotein M-bound sphingosine-1-phosphate regulates blood–brain barrier paracellular permeability and transcytosis
por: Mathiesen Janiurek, Mette, et al.
Publicado: (2019)

Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
por: Dickson, Elna, et al.
Publicado: (2022)

Effects of excitotoxicity in the hypothalamus in transgenic mouse models of Huntington disease
por: Henningsen, Jo B., et al.
Publicado: (2021)

Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
por: Thomsen, Maj Schneider, et al.
Publicado: (2022)

Dexmedetomidine exerts an anti-inflammatory effect via α2 adrenoceptors to alleviate cognitive dysfunction in 5xFAD mice
por: Luo, Su-mei, et al.
Publicado: (2022)

Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood–Brain Barrier Adherence, Uptake, and Permeation
por: Kristensen, Mie, et al.
Publicado: (2020)

Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington’s disease R6/2 mice
por: Soylu-Kucharz, Rana, et al.
Publicado: (2017)

Microarray profiling of hypothalamic gene expression changes in Huntington’s disease mouse models
por: Dickson, Elna, et al.
Publicado: (2022)

Metabolic and behavioral effects of mutant huntingtin deletion in Sim1 neurons in the BACHD mouse model of Huntington’s disease
por: Soylu-Kucharz, Rana, et al.
Publicado: (2016)

IKKβ signaling mediates metabolic changes in the hypothalamus of a Huntington disease mouse model
por: Soylu-Kucharz, Rana, et al.
Publicado: (2022)

Contributions of blood–brain barrier imaging to neurovascular unit pathophysiology of Alzheimer’s disease and related dementias
por: Uchida, Yuto, et al.
Publicado: (2023)

Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington’s disease
por: Stan, Tiberiu Loredan, et al.
Publicado: (2020)

Genetic background influences the 5XFAD Alzheimer's disease mouse model brain proteome
por: Hurst, Cheyenne D., et al.
Publicado: (2023)

Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
por: Elabi, Osama, et al.
Publicado: (2021)

Endothelial Dysfunction and Impaired Neurovascular Coupling Responses Precede Cognitive Impairment in a Mouse Model of Geriatric Sepsis
por: Csipo, Tamas, et al.
Publicado: (2021)

Decanoic Acid Rescues Differences in AMPA-Mediated Calcium Rises in Hippocampal CA1 Astrocytes and Neurons in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Abghari, Mina, et al.
Publicado: (2023)

Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue
por: Soylu-Kucharz, Rana, et al.
Publicado: (2015)

Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice
por: Prange-Kiel, Janine, et al.
Publicado: (2016)

Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles
por: Kucharz, Krzysztof, et al.
Publicado: (2021)

FAD-deficient P187S mutation of NAD(P)H:quinone oxidoreductase 1 (NQO1*2) binds and accelerates β-amyloid aggregation
por: Panja, Sudipta, et al.
Publicado: (2022)

Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease
por: Wang, Lu, et al.
Publicado: (2016)

Axonal and myelinic pathology in 5xFAD Alzheimer’s mouse spinal cord
por: Chu, Tak-Ho, et al.
Publicado: (2017)

The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2020)

Retinal hyperspectral imaging in the 5xFAD mouse model of Alzheimer’s disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2021)

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease
por: Forner, Stefania, et al.
Publicado: (2021)

Therapeutic Effects of Aripiprazole in the 5xFAD Alzheimer’s Disease Mouse Model
por: Jeong, Ye Ji, et al.
Publicado: (2021)

Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease
por: Andersen, Jens V., et al.
Publicado: (2021)

Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET
por: Oh, Se Jong, et al.
Publicado: (2018)

Retinal Functional and Structural Changes in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Lim, Jeremiah K. H., et al.
Publicado: (2020)

Upregulation of Vitamin C Transporter Functional Expression in 5xFAD Mouse Intestine
por: Teafatiller, Trevor, et al.
Publicado: (2021)

Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
por: Choi, Hee-Jeong, et al.
Publicado: (2022)

Cortical cerebrovascular and metabolic perturbations in the 5xFAD mouse model of Alzheimer’s disease
por: Jullienne, Amandine, et al.
Publicado: (2023)

Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease
por: Nizari, Shereen, et al.
Publicado: (2022)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

Antenatal Hypoxia Accelerates the Onset of Alzheimer’s Disease Pathology in 5xFAD Mouse Model
por: Shen, Guofang, et al.
Publicado: (2020)

Impact of Gut Microbiome Manipulation in 5xFAD Mice on Alzheimer’s Disease-Like Pathology
por: Guilherme, Malena dos Santos, et al.
Publicado: (2021)

Longitudinal GluCEST MRI Changes and Cerebral Blood Flow in 5xFAD Mice
por: Igarashi, Hironaka, et al.
Publicado: (2020)

Brain and Retinal Abnormalities in the 5xFAD Mouse Model of Alzheimer's Disease at Early Stages
por: Zhang, Mengrong, et al.
Publicado: (2021)

Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer’s Disease
por: Karaahmet, Berke, et al.
Publicado: (2023)

Age and Sex Differences in Heart Failure With Preserved Ejection Fraction
por: Kobak, Kamil Aleksander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nf0jkh3iqqov86sqrv36hq4dlf